WELL Health Technologies Corp. (TSX-V:WELL) has a proven board and management team with a track record of managing operational growth and strategic acquisitions:


Hamed Shahbazi | Chairman & CEO

  • 20+ years of Experience as technology focused operator
  • Founded TIO Networks (TSXV:TNC) as a kiosk solution provider in 1997 and has transitioned it into a multi-channel payment solution provider specializing in bill payment and other financial services. TIO Networks was acquired by PayPal (Nasdaq: PYPL) for CAD$304 million (Jul 2017)
  • Has extensive strategic Mergers, Acquisitions and Divestitures experience as an operator (eg. TIO) and board member (BBTV, WELL, etc) with more than a dozen successful transactions
  • The Cantech Letter named Mr. Shahbazi the TSX Venture Tech “Exec of the Year” three years in a row (2014 – 2016) and TIO Networks the TSX Venture Tech “Stock of the Year” two years in a row (2014 – 2015)

Brian Levinkind | Chief Financial Officer

  • Over 20 years experience as a Chartered Accountant (now CPA), both public & private. Brian has been involved in the planning, structuring and implementation of numerous financings, mergers, acquisitions and corporate reorganizations
  • Former equity partner at Grant Thornton LLP in Canada, specializing in tax and mergers and acquisitions. Brian has also held management positions at HSBC and KPMG
  • Extensive Chief Financial Officer experience in the healthcare and clean energy sectors

Alex Read | COO

  • 16 years experience in entrepreneurial hyper-growth enterprises such as 1-800-GOT-JUNK?, Foodee, You Move Me, WOW!, and other franchise businesses
  • Recently completed a turnaround and sale of a distribution focused manufacturing business, and previous business restructuring experience through a senior leadership role at American Express
  • “Forty Under 40” award winner by Business in Vancouver in 2007
  • Previously the Global Chair for the Entrepreneurs Organization (EO), “Global Student Entrepreneurs Award” (GSEA), and past Regional Director for the Canadian region of EO

Dr. Michael Frankel | Director of Medical Clinic Operations

  • Graduate of the University of the Witwatersrand in Johannesburg, South Africa, completing his internship at Addington Hospital in Durban, South Africa
  • He came to Canada in 1990, where he initially worked as a General Practitioner in Northern Manitoba.  He moved to Vancouver in 1991 and initially worked as a Clinical Assistant in Pediatric Oncology at the BC Children's Hospital
  • Since 1992, Dr. Frankel has worked as a General Practitioner in the Lower Mainland.  He owns and operates a portfolio of successful Primary Healthcare facilities, as well as continuing to be a practicing physician


Thomas Liston | CFA– Independent Director

  • Currently Managing Partner at Difference Capital Financial, which provides debt and equity growth capital to mainly late-stage private companies with a focus on technology, media, and healthcare
  • Previously, Mr. Liston was a top-ranked research analyst covering the technology sector
  • He currently sits on the board of Mogo Finance Technology (TSX: MOGO) Inc and served as a Director of QHR Technologies Inc. (TSX-V: QHR), which was sold to Loblaw Companies Limited (TSX: L) in the fall of 2016 for +$170M

John Kim | Independent Director

  • John Kim is a Toronto based businessman and award-winning Institutional Investor for over 20 years with an extensive capital markets network
  • His investment focus has included companies from a variety of sectors, including technology, healthcare, and resources at various stages of development, ranging from early start-ups and to Fortune 1000 Companies
  • John has both public and private company board experience and has participated in the Company’s two prior financings with his own personal capital

Ken Cawkell | Independent Director

  • Member of the BC Bar Association, and co-founder of Cawkell Brodie LLP for the last 30-years
  • For over 25 years, he has been involved in various industries within public, private and venture capital
  • He is also a founder of Neurodyn Life Sciences Inc., a private biotech company focused on developing natural based products to treat Alzheimer’s and other neurodegenerative diseases

Peter Maclean | Independent Director

  • Spent most of the last 30 years working as a director for several public companies
  • Has played a significant role in raising more than $100 million of equity capital
  • Peter is an Economist by trade, having received his MA (economics) from New Brunswick University and briefly working for the New Brunswick Provincial Government

Submitting Form...

The server encountered an error.

Form received.

2018 Well Health Technologies Corp.

Receive News and Updates on WELL Health Technologies Corp.